Delwel GO - Search Results

1

Methodological quality of economic evaluations of new pharmaceuticals in The Netherlands.

Hoomans T, Severens JL, van der Roer N, Delwel GO. Hoomans T, et al. Among authors: delwel go. Pharmacoeconomics. 2012 Mar;30(3):219-27. doi: 10.2165/11539850-000000000-00000. Pharmacoeconomics. 2012. PMID: 22074610

2

[Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].

Hoomans T, van der Roer N, Severens JL, Delwel GO. Hoomans T, et al. Among authors: delwel go. Ned Tijdschr Geneeskd. 2010;154:A958. Ned Tijdschr Geneeskd. 2010. PMID: 20699045 Dutch.

3

[Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget].

Delwel GO, Sprenger MJ. Delwel GO, et al. Ned Tijdschr Geneeskd. 2002 Jun 8;146(23):1068-71. Ned Tijdschr Geneeskd. 2002. PMID: 12085554 Dutch.

4

Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The Netherlands.

Franken MG, van Gils CW, Gaultney JG, Delwel GO, Goettsch W, Huijgens PC, Steenhoek A, Punt CJ, Koopman M, Redekop WK, Uyl-de Groot CA. Franken MG, et al. Among authors: delwel go. Eur J Cancer. 2013 Jan;49(1):8-16. doi: 10.1016/j.ejca.2012.06.010. Epub 2012 Jul 16. Eur J Cancer. 2013. PMID: 22809557

5

[Pharmacotherapeutic care for vulnerable groups with polypharmacy has to get better].

Lemmens LC, Delwel GO, Meijler AP, Weda M. Lemmens LC, et al. Among authors: delwel go. Tijdschr Gerontol Geriatr. 2015 Sep;46(4):189-95. doi: 10.1007/s12439-015-0137-1. Tijdschr Gerontol Geriatr. 2015. PMID: 25987444 Dutch.

6

A baseline assessment by healthcare professionals of Dutch pharmacotherapeutic care for the elderly with polypharmacy.

Bakker L, Kemper PF, Wagner C, Delwel GO, de Bruijne MC. Bakker L, et al. Among authors: delwel go. Eur J Public Health. 2017 Aug 1;27(4):679-686. doi: 10.1093/eurpub/ckx076. Eur J Public Health. 2017. PMID: 28637234

7

[The conversation with the patient is essential for good pharmacotherapeutic care].

Lemmens LC, Delwel GO, Hoefman RJ, de Jong JD, Weda M. Lemmens LC, et al. Among authors: delwel go. Tijdschr Gerontol Geriatr. 2018 Apr;49(2):56-59. doi: 10.1007/s12439-018-0247-7. Tijdschr Gerontol Geriatr. 2018. PMID: 29411319 Dutch.

8

Identification of the cleavage sites in the alpha6A integrin subunit: structural requirements for cleavage and functional analysis of the uncleaved alpha6Abeta1 integrin.

Delwel GO, Kuikman I, van der Schors RC, de Melker AA, Sonnenberg A. Delwel GO, et al. Biochem J. 1997 May 15;324 ( Pt 1)(Pt 1):263-72. doi: 10.1042/bj3240263. Biochem J. 1997. PMID: 9164866 Free PMC article.

9

The A and B variants of the alpha 3 integrin subunit: tissue distribution and functional characterization.

de Melker AA, Sterk LM, Delwel GO, Fles DL, Daams H, Weening JJ, Sonnenberg A. de Melker AA, et al. Among authors: delwel go. Lab Invest. 1997 Apr;76(4):547-63. Lab Invest. 1997. PMID: 9111516

10

Cleavage of the alpha6A subunit is essential for activation of the alpha6Abeta1 integrin by phorbol 12-myristate 13-acetate.

Delwel GO, Hogervorst F, Sonnenberg A. Delwel GO, et al. J Biol Chem. 1996 Mar 29;271(13):7293-6. doi: 10.1074/jbc.271.13.7293. J Biol Chem. 1996. PMID: 8631745 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters